Literature DB >> 15993407

Cyclooxygenase-2 in cancer cells and macrophages induces colon cancer cell growth by cigarette smoke extract.

Edgar S L Liu1, Vivian Y Shin, Yi-Ni Ye, Jiing-Chyuan Luo, William K K Wu, Chi-Hin Cho.   

Abstract

Cigarette smoking, cyclooxygenase-2 (COX-2) and macrophages are independently associated with colorectal cancer. In the present study, cigarette smoke ethanol extract was applied to colon cancer cells (SW1116) or indirectly via activated macrophages (THP-1 cells) to attest their effects on cancer cell proliferation and tumor growth both in vitro and in vivo. Ethanol extract induced COX-2 expression in SW1116 and THP-1 cells. Combination of THP-1 pre-incubated medium and ethanol extract further potentiated COX-2 expression and proliferation of SW1116 cells. Tumor growth in nude mice was positively associated with the medium and/or ethanol extract treatments, together with the up-regulation of cell proliferation and angiogenesis, and down-regulation of apoptosis. Application of a COX-2 inhibitor (SC236) reduced tumor growth as well as cell proliferation and angiogenesis. These actions are partially depended on the decrease of COX-2 expression. Taken together, inhibition of COX-2 activity may have significant implication to prevent colon cancer in smokers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993407     DOI: 10.1016/j.ejphar.2005.05.018

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  The biological and clinical effects of smoking by patients with cancer and strategies to implement evidence-based tobacco cessation support.

Authors:  Graham W Warren; Samantha Sobus; Ellen R Gritz
Journal:  Lancet Oncol       Date:  2014-10-26       Impact factor: 41.316

2.  Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.

Authors:  M Pazianas; B Abrahamsen; P A Eiken; R Eastell; R Graham G Russell
Journal:  Osteoporos Int       Date:  2012-03-06       Impact factor: 4.507

3.  Esophageal COX-2 expression is increased in Barrett's esophagus, obesity, and smoking.

Authors:  Theresa Nguyen; Zhouwen Tang; Mamoun Younes; Abeer Alsarraj; David Ramsey; Stephanie Fitzgerald; Jennifer R Kramer; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2014-09-04       Impact factor: 3.199

4.  Studies on the Contribution of Cox-2 Expression in the Progression of Oral Squamous Cell Carcinoma and H-Ras Activation.

Authors:  Abdolkarim Moazeni-Roodi; Abdolamir Allameh; Iraj Harirchi; Maziar Motiee-Langroudi; Ata Garajei
Journal:  Pathol Oncol Res       Date:  2016-09-15       Impact factor: 3.201

5.  The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines.

Authors:  Takaya Matsuzuka; Kathryn Miller; Lara Pickel; Chiyo Doi; Rie Ayuzawa; Masaaki Tamura
Journal:  Mol Cell Biochem       Date:  2008-10-01       Impact factor: 3.396

6.  Cyclooxygenase 2 polymorphism and colorectal cancer: -765G>C variant modifies risk associated with smoking and body mass index.

Authors:  Li-Li Xing; Zhen-Ning Wang; Li Jiang; Yong Zhang; Ying-Ying Xu; Juan Li; Yang Luo; Xue Zhang
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

7.  Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells.

Authors:  Prerna Rastogi; Dawn M Young; Jane McHowat
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-12       Impact factor: 5.464

8.  LKB1/PEA3/ΔNp63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure.

Authors:  Edward A Ratovitski
Journal:  Oxid Med Cell Longev       Date:  2010-09-01       Impact factor: 6.543

9.  Expression of COX-2, NF-kappaB-p65, NF-kappaB-p50 and IKKalpha in malignant and adjacent normal human colorectal tissue.

Authors:  M P Charalambous; T Lightfoot; V Speirs; K Horgan; N J Gooderham
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.